118 related articles for article (PubMed ID: 6084638)
21. Peritoneal lavage efficiently eliminates protease-alpha-2-macroglobulin complexes and components of the contact system from the peritoneal cavity in patients with severe acute pancreatitis.
Aasen AO; Ruud TE; Roeise O; Bouma BN; Stadaas JO
Eur Surg Res; 1989; 21(1):1-10. PubMed ID: 2469582
[TBL] [Abstract][Full Text] [Related]
22. The elimination in dogs of trypsin-alpha-macroglobulin complexes inactivated by the Kazal or the Kunitz inhibitor.
Eddeland A; Ohlsson K
Hoppe Seylers Z Physiol Chem; 1978 Mar; 359(3):379-84. PubMed ID: 76602
[TBL] [Abstract][Full Text] [Related]
23. Hyperoncotic dextran and systemic aprotinin in necrotizing rodent pancreatitis.
Huch K; Schmidt J; Schratt W; Sinn HP; Buhr H; Herfarth C; Klar E
Scand J Gastroenterol; 1995 Aug; 30(8):812-6. PubMed ID: 7481552
[TBL] [Abstract][Full Text] [Related]
24. Effects of protease inhibitor pretreatment on hemodynamic performances and survival rate in experimental, acute pancreatitis.
Ruud TE; Aasen AO; Pillgram-Larsen J; Stadaas J; Aune S
Adv Exp Med Biol; 1986; 198 Pt B():413-21. PubMed ID: 2433916
[TBL] [Abstract][Full Text] [Related]
25. Effect of microemulsion formulation on biodistribution of
İlem-Özdemir D; Üstündağ-Okur N; Ay Şenyiğit Z; Oruç N; Aşıkoğlu M; Özütemiz Ö; Karasulu HY
Drug Deliv; 2016 Oct; 23(8):3055-3062. PubMed ID: 26923781
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics of aprotinin in preoperative cardiac surgical patients.
Levy JH; Bailey JM; Salmenperä M
Anesthesiology; 1994 May; 80(5):1013-8. PubMed ID: 7517106
[TBL] [Abstract][Full Text] [Related]
27. The effect of peritoneal dialysis with and without aprotinin on acute experimental pancreatitis in rats.
Tilquin BM; O'Connor TC; Hancotte-La Haye CM; Gonze DM; Reynaert MS; De Muylder CG; Kestens PJ
Int Surg; 1990; 75(3):174-8. PubMed ID: 1700770
[TBL] [Abstract][Full Text] [Related]
28. Proteinases and inhibitors in plasma and peritoneal exudate in acute pancreatitis.
Wendt P; Fritsch A; Schulz F; Wunderlich G; Blümel G
Hepatogastroenterology; 1984 Dec; 31(6):277-81. PubMed ID: 6083967
[TBL] [Abstract][Full Text] [Related]
29. [Pathophysiology and treatment of severe pancreatitis].
Koh I; Satake K; Umeyama K
Nihon Geka Gakkai Zasshi; 1985 Sep; 86(9):1249-52. PubMed ID: 4088246
[TBL] [Abstract][Full Text] [Related]
30. Aprotinin revisited: formulation, characterization, biodistribution and therapeutic potential of new aprotinin microemulsion in acute pancreatitis.
Karasulu HY; Oruç N; Üstündağ-Okur N; İlem Özdemir D; Ay Şenyiğit Z; Barbet Yılmaz F; Aşıkoğlu M; Özkılıç H; Akçiçek E; Güneri T; Özütemiz Ö
J Drug Target; 2015; 23(6):525-37. PubMed ID: 25738992
[TBL] [Abstract][Full Text] [Related]
31. Aprotinin in severe acute pancreatitis.
Smith M; Kocher HM; Hunt BJ
Int J Clin Pract; 2010 Jan; 64(1):84-92. PubMed ID: 19178597
[TBL] [Abstract][Full Text] [Related]
32. Influence of plasma proteinase inhibitors and aprotinin on trypsin-induced bradykinin release in vitro in man.
Lasson A; Dittmann B; Ohlsson K
Hoppe Seylers Z Physiol Chem; 1983 Sep; 364(9):1315-22. PubMed ID: 6195066
[TBL] [Abstract][Full Text] [Related]
33. Effective intraperitoneal antiprotease therapy for taurocholate-induced pancreatitis in rats.
Wilson C; Imrie CW
Br J Surg; 1990 Nov; 77(11):1252-5. PubMed ID: 1701328
[TBL] [Abstract][Full Text] [Related]
34. Immunoreactive forms of cationic trypsin in plasma and ascitic fluid of dogs in experimental pancreatitis.
Geokas MC; Largman C; Durie PR; Brodrick JW; Ray SB; O'Rourke M; Vollmer J
Am J Pathol; 1981 Oct; 105(1):31-9. PubMed ID: 6170231
[TBL] [Abstract][Full Text] [Related]
35. Effects on peritoneal proteolysis and hemodynamics of prophylactic infusion with C1 inhibitor in experimental acute pancreatitis.
Ruud TE; Aasen AO; Pillgram-Larsen J; Stadaas JO
Scand J Gastroenterol; 1986 Oct; 21(8):1018-24. PubMed ID: 2430330
[TBL] [Abstract][Full Text] [Related]
36. Early phase components of the kallikrein kinin system in hemorrhagic ascitic fluid and plasma in the rat with induced acute pancreatitis.
Seung WP; Feldman BF
Am J Vet Res; 1985 Sep; 46(9):1961-6. PubMed ID: 2413790
[TBL] [Abstract][Full Text] [Related]
37. TRYPSIN INHIBITOR IN ACUTE HEMORRHAGIC PANCREATITIS IN DOGS; EFFECT.
KELLY TR; BRATCHER EP; FALOR WH
Arch Surg; 1964 Aug; 89():317-21. PubMed ID: 14160159
[No Abstract] [Full Text] [Related]
38. Effects of protease inhibitors on coagulation abnormalities in acute canine pancreatitis.
Izquierdo R; Sandberg L; Squillaci G; Hoppensteadt D; Walenga J; Fareed J; Prinz R
Am Surg; 1984 Jun; 50(6):317-23. PubMed ID: 6203448
[TBL] [Abstract][Full Text] [Related]
39. Comparison of three dose regimens of aprotinin in infants undergoing the arterial switch operation.
Verma YS; Chauhan S; Bisoi AK; Gharde P; Kiran U; Das SN
Ann Card Anaesth; 2010; 13(2):110-5. PubMed ID: 20442540
[TBL] [Abstract][Full Text] [Related]
40. Comparative study of protease inhibitors on coagulation abnormalities in canine pancreatitis.
Izquierdo R; Sandberg L; Nora MO; Squillaci G; Hoppensteadt D; Walenga J; Fareed J; Prinz RA
J Surg Res; 1984 Jun; 36(6):606-13. PubMed ID: 6202958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
